Projects

Overview of projects financed with external funds.

ESTSURV

The project aims to automate the collection of national infectious disease surveillance data, improve its quality and enable more accurate analysis. Great emphasis is placed on reducing manual work and ensuring that data is uniformly accessible within information systems.

The project has five objectives:

1. Improving and refining the national infectious disease surveillance and monitoring system. An interface will be created between the infectious disease laboratory and the infectious disease information system to enable automated data exchange and reduce the amount of data transmitted manually.

2. To create a prototype for the automatic exchange of data between hospital beds to help solve the data problems that arose during the COVD-19 crisis.

3. Train healthcare workers to enter high-quality data into information systems, particularly when reporting infectious disease information.

4. Improve influenza surveillance and monitoring, focusing on healthcare worker involvement and the quality and timeliness of data.

5. Develop genetic epidemiology data analysis and sharing to improve the efficiency of research related to disease outbreaks.

Co-funded by the European Union

Project duration: 2025–2027

EU-JAMRAI 2

The Health Board participates in the EU joint project „Joint Action Antimicrobial Resistance and Healthcare-Associated Infections", which is a continuation of the previous JAMRAI project (2017–2021).

The goal of JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) by implementing joint and coordinated actions across Europe. JAMRAI is dedicated to promoting interdisciplinary cooperation between countries, institutions, and sectors in order to preserve the effectiveness of antimicrobial agents and protect public health both now and in the future.

More than 120 partners from 30 countries have joined the project.

Project duration: 2024–2028

EU-JAMRAI website

PARC

The international project PARC (Partnership for the Assessment of Risks from Chemicals) runs for seven years (1 May 2022–30 April 2029) and is funded by the European Union and participating Member States. The project is coordinated by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES).

The programme aims to develop a pan-European research and innovation platform for assessing the health risks of chemicals. Within the framework of the programme, tools are being developed to improve the assessment of risks posed by chemicals to both human health and the environment.

More than 200 organisations from 30 European countries have joined the programme. In Estonia, in addition to the Health Board, the Ministry of Social Affairs and the University of Tartu are participating in the project. As the signatory of the grant agreement, the Health Board coordinates cooperation and information exchange with third parties and the national network.

Read more

Project duration: 2022–2029

PARC website

Mitigation of the risk of parasites, in particular in waterworks using surface water (especially during periods of flooding) and identification of the risk of blue-green algae toxin

The Health Board implemented a project aimed at assessing the quality of drinking water supplied by surface water systems (the Tallinn surface water supply area, as well as the water supply systems of the cities of Harku and Narva) from the source to the consumer’s tap.

Within the framework of the project, the levels of Giardia cysts, Cryptosporidium oocysts, and the cyanobacterial toxin microcystin-LR were monitored over the course of one year, most frequently once per week. Knowledge of the occurrence of parasites and cyanobacterial toxins helps ensure compliant and safe drinking water quality for the population.

The project was funded by the Environmental Investment Centre.

logo "KIK TOETAB"

Project duration: 2024–2026

Project study report | 2.66 MB | pdf

OH4Surveillance

The project „Setting up a coordinated surveillance system under the One Health approach“, OH4Surveillance) is funded by the European Union and aims to strengthen Estonia’s vector surveillance system through international cooperation and the One Health approach.

In Estonia, the project is led by the National Centre for Laboratory Research and Risk Assessment (LABRIS) in cooperation with the Agriculture and Food Board, the Estonian University of Life Sciences, and the Health Board.

In Estonia, the project focuses on improving the monitoring and analysis of vector-borne diseases. The priority diseases are tick-borne encephalitis and Lyme borreliosis, which are the main vector-related public health threats. In addition, the project addresses the West Nile virus, whose potential for spread has increased due to climate change, as well as a previously unknown pathogenic disease Y, which occurs in animals and may also be transmitted to humans.

The Health Board’s role primarily involves developing the surveillance system for tick-borne diseases — collecting ticks and analysing them for the pathogens that cause tick-borne encephalitis and Lyme borreliosis.

Along with Estonia, the project involves Belgium, Lithuania, Luxembourg, Latvia, Norway, Poland, Sweden, Germany, Finland, and Denmark.

OneHealth4Surveillance logo

Project duration: 2024–2026

OH4Surveillance leaflet | 5.62 MB | pdf

Last updated: 06.03.2026

search block image